Extended-release pharmacotherapies for Substance Use Disorders in incarcerated populations

A history of harmful substance use or dependence is common among people in Criminal Justice Systems (CJSs) around the world. The time after an individual has left the CJS is of elevated risk for those with harmful substance use - with high rates of relapse, accidental overdose and suicide. Despite this, there is often poor access to treatments while incarcerated or on release from the CJS. This webinar looked at a PRISMA-compliant systematic review that was conducted to explore the evidence for extended-release substance use pharmacotherapy for incarcerated or recently released participants (less than 3 months).